Treatment factors associated with survival in early-stage oral cavity cancer: Analysis of 6830 cases from the National Cancer Data Base

JAMA Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 7, 2015, Pages 593-598

  Luryi, Alexander L ^a   Chen, Michelle M ^a   Mehra, Saral ^a   Roman, Sanziana A ^b   Sosa, Julie A ^b,c   Judson, Benjamin L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; MOUTH CAVITY; MOUTH SQUAMOUS CELL CARCINOMA; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NECK DISSECTION; ORAL SURGERY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL ANATOMY; SURVIVAL RATE; UNIVARIATE ANALYSIS; ADJUVANT THERAPY; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FACTUAL DATABASE; MORTALITY; MOUTH NEOPLASMS; PATHOLOGY; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84937919400     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2015.0719     Document Type: Article

References (32)

1. American Cancer Society. Cancer Facts & Figures 2014. http: //www.cancer.org/research /cancerfactsstatistics/cancerfactsfigures2014/. Accessed June 21, 2014.
2. Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: A period analysis. Oncologist. 2010; 15 (9) : 994-1001.
3. Shiboski CH, Shiboski SC, Silverman S Jr. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 2000; 28 (4) : 249-256.
4. Tai SK, LiWY, Yang MH, et al. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: Neck dissection and postoperative adjuvant therapy. Ann Surg Oncol. 2012; 19 (6) : 1995-2002.
5. Beenken SW, Krontiras H, MaddoxWA, Peters GE, Soong S, Urist MM. T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection. Head Neck. 1999; 21 (2) : 124-130.
6. Yuen AP, Lam KY, Chan AC, et al. Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg. 1999; 177 (1) : 90-92.
7. D'Cruz AK, Siddachari RC,Walvekar RR, et al. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial. Head Neck. 2009; 31 (5) : 618-624.
8. National Comprehensive Cancer Network. Head and neck cancers. http: //www.nccn.org /professionals/physician-gls/PDF/head-and-neck .pdf. Accessed October 8, 2013.
9. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005; 29 (2) : 167-178.
10. Chen TC,Wang CP, Ko JY, Yang TL, Lou PJ. The impact of pathologic close margin on the survival of patients with early stage oral squamous cell carcinoma. Oral Oncol. 2012; 48 (7) : 623-628.
11. Jones AS, Bin Hanafi Z, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? a study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996; 74 (1) : 128-132.
12. Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive surgical margins in early stage oral cavity cancer: An analysis of 20,602 cases. Otolaryngol Head Neck Surg. 2014; 151 (6) : 984-990.
13. Hinni ML, Ferlito A, Brandwein-Gensler MS, et al. Surgical margins in head and neck cancer: A contemporary review. Head Neck. 2013; 35 (9) : 1362-1370.
14. Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of cases captured in the National Cancer Data Base with those in population-based central cancer registries. Ann Surg Oncol. 2013; 20 (6) : 1759-1765.
15. American College of Surgeons. National Cancer Data Base. http: //www.facs.org/cancer/ncdb /index.html. Accessed October 30, 2013.
16. American College of Surgeons. About CoC accreditation. http: //www.facs.org/cancer/coc /whatis.html. Accessed November 4, 2013.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45 (6) : 613-619.
18. Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl. 1995; 77 (5) : 325-331.
19. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: Epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010; 39 (4) : 299-305.
20. Lassig AA, Joseph AM, Lindgren BR, et al. The effect of treating institution on outcomes in head and neck cancer. Otolaryngol Head Neck Surg. 2012; 147 (6) : 1083-1092.
21. Gaspar LE, McNamara EJ, Gay EG, et al. Small-cell lung cancer: Prognostic factors and changing treatment over 15 years. Clin Lung Cancer. 2012; 13 (2) : 115-122.
22. Cheung MC, Koniaris LG, Perez EA, MolinaMA, GoodwinWJ, Salloum RM. Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol. 2009; 16 (4) : 1001-1009.
23. Kwok J, Langevin SM, Argiris A, Grandis JR, Gooding WE, Taioli E. The impact of health insurance status on the survival of patients with head and neck cancer. Cancer. 2010; 116 (2) : 476-485.
24. Robbins AS, Pavluck AL, Fedewa SA, Chen AY, Ward EM. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol. 2009; 27 (22) : 3627-3633.
25. Chen TY, Emrich LJ, Driscoll DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys. 1987; 13 (6) : 833-837.
26. Liao CT, Chang JT,Wang HM, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008; 15 (3) : 915-922.
27. Barry CP, Katre C, Papa E, et al. De-escalation of surgery for early oral cancer: Is it oncologically safe? Br J Oral Maxillofac Surg. 2013; 51 (1) : 30-36.
28. Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol. 2011; 29 (2) : 186-191.
29. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S,Werner JA, Sesterhenn AM. Ameta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol. 2011; 47 (5) : 320-324.
30. Chinn SB, SpectorME, Bellile EL, et al. Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013; 149 (6) : 893-899.
31. Jones HB, Sykes A, Bayman N, et al. The impact of lymphovascular invasion on survival in oral carcinoma. Oral Oncol. 2009; 45 (1) : 10-15.
32. Rogers SN, Brown JS,Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009; 45 (3) : 201-211.